Abingdon Health enters development deal with European client
(Alliance News) - Abingdon Health PLC on Thursday said it had signed a master service agreement for a new EUR2 million contract with an unnamed customer. Read More
(Alliance News) - Abingdon Health PLC on Thursday said it had signed a master service agreement for a new EUR2 million contract with an unnamed customer. Read More
(Alliance News) - Abingdon Health PLC on Monday expressed confidence in meeting full-year revenue expectations as it said it has continued executing on strategic milestones. Read More
(Alliance News) - European stocks were higher at midday on Monday, following reports of accelerated business activity in the eurozone for a third consecutive month, and investor hopes for a more targeted approach from US tariffs. Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News: Read More
Abingdon Health PLC - London-based developer of rapid-flow diagnostic tests - Says saliva-based pregnancy test Salistick to be launched in various key European territories including Austria, Poland and Germany. Salistick is based on technology by Jerusalem-based saliva diagnostics firm Salignostics, with which Abingdon has extended its distribution agreement. Abingdon says it previously successfully launched Salistick in the UK, and that the agreement for the German market is on an exclusive basis. Abingdon and distribution partner NeutraPharma expect to launch own-brand Salistick with various "major German retailers" in the second quarter of this calendar year. Says it has received an initial purchase order for 70,000 tests with further orders expected during 2025 on a quarterly basis. Read More
(Correcting erroneous currency) Read More
(Alliance News) - Abingdon Health PLC on Monday said it had been allocated EUR800,000 worth of funds to develop malaria tests. Read More
Abingdon Health PLC - York, England-based lateral flow contract research and contract development & manufacturing organisation - Says subsidiary CS (Lifesciences) Ltd has won a 12-month contract with an unnamed global diagnostics company, due to begin in March. The contract provides revenue of just under GBP500,000 and will see CS (Lifesciences) carry out work relating to quality management systems and regulatory approvals. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More
(Alliance News) - Abingdon Health PLC on Tuesday announced it has signed a lease to open a commercial office and laboratory in Wisconsin, US. Read More
(Alliance News) - Abingdon Health PLC on Tuesday said it has narrowed its annual loss, as revenue grows more than 50% amid increased customer activity. Read More
Abingdon Health PLC - York, England-based lateral flow contract research and contract development & manufacturing organisation - Aims to raise up to GBP500,000 from a retail offer of shares at 9.75 pence each, the same price at while it raised GBP5.2 million from a share placing with institutional investors. The retail offer opens on Monday and closes on Wednesday next week. The equity raise comes as Abingdon completes its acquisition of CS Lifesciences group, which trades as Compliance Solutions and offers consultancy on meeting medical regulatory compliance requirements. Abingdon issues 9.2 million initial consideration shares for the acquisition. Read More
(Alliance News) - Abingdon Health PLC on Tuesday reported double-digit revenue growth in each of its divisions. Read More
(Alliance News) - Abingdon Health PLC on Wednesday said its saliva pregnancy self test is now available across the UK and online. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Abingdon Health PLC announced on Wednesday that it will provide Boots UK Ltd with rapid lateral flow self-tests to be sold under the Boots own brand label. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More